Pages that link to "Q35998992"

The following pages link to Generic low-molecular-weight heparins: some practical considerations (Q35998992):

Displaying 21 items.

• Characterization of anticoagulant heparinoids by immunoprofiling (Q33376879) (← links)
• Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange. (Q33685447) (← links)
• Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees (Q33765274) (← links)
• Comparative glycomics using a tetraplex stable-isotope coded tag. (Q33789401) (← links)
• Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin (Q33790809) (← links)
• Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery (Q34635335) (← links)
• Effect of Fraxiparine, a type of low molecular weight heparin, on the invasion and metastasis of lung adenocarcinoma A549 cells (Q36216588) (← links)
• Low-molecular-weight heparins and angiogenesis (Q36414904) (← links)
• Management of venous thromboembolism in patients with cancer: role of dalteparin (Q36812767) (← links)
• Heparin as an inhibitor of cancer progression. (Q37784315) (← links)
• The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines. (Q39252361) (← links)
• The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro (Q39963957) (← links)
• Dalteparin, a low‐molecular‐weight heparin, promotes angiogenesis mediated by heparin‐binding VEGF‐A in vivo (Q41212817) (← links)
• Cost-effectiveness of bemiparin in the prevention and treatment of venous thromboembolism. (Q43042778) (← links)
• Determination of the molecular weight of low-molecular-weight heparins by using high-pressure size exclusion chromatography on line with a triple detector array and conventional methods. (Q46753849) (← links)
• Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products (Q47188749) (← links)
• Effect of a low molecular weight heparin molecule, dalteparin, on cellular apoptosis and inflammatory process in an incisional wound-healing model. (Q47290323) (← links)
• Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation (Q47290768) (← links)
• A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). (Q47316913) (← links)
• Generic versions of enoxaparin available for clinical use in Brazil are similar to the original drug (Q84014374) (← links)
• Parnaparin : a review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disorders (Q94608941) (← links)